{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T04:20:08Z","timestamp":1788841208548,"version":"build-2803163510"},"reference-count":67,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007735","name":"Deutsche Gesellschaft f\u00fcr Neurologie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1053\/j.ajkd.2025.10.021","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T16:50:28Z","timestamp":1772038228000},"page":"841-851","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Vaccinations to Prevent Infections in Adult Individuals With CKD and After Kidney Transplantation: A Review"],"prefix":"10.1053","volume":"87","author":[{"given":"Matthias","family":"Girndt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1053\/j.ajkd.2025.10.021_bib1","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1053\/j.ajkd.2011.07.012","article-title":"The risk of infection-related hospitalization with decreased kidney function","volume":"59","author":"Dalrymple","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1053\/j.ajkd.2025.10.021_bib2","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/s41581-022-00617-5","article-title":"Vaccination in patients with kidney failure: lessons from COVID-19","volume":"18","author":"Babel","year":"2022","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2025.10.021_bib3","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000320143","article-title":"Clinical features of 2009 pandemic influenza A (H1N1) virus infection in chronic hemodialysis patients","volume":"30","author":"Li","year":"2010","journal-title":"Blood Purif"},{"issue":"5","key":"10.1053\/j.ajkd.2025.10.021_bib4","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/cid\/ciae613","article-title":"Glucocorticoid dosing and implications for vaccination: evolution of global definitions","volume":"80","author":"Wang","year":"2025","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.ajkd.2025.10.021_bib5","article-title":"Longitudinal evaluation of the impact of immunosuppressive regimen on immune responses to COVID-19 vaccination in kidney transplant recipients","volume":"9","author":"Wiedemann","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"10.1053\/j.ajkd.2025.10.021_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2024.106133","article-title":"Mycophenolate mofetil hampers antibody responses to a broad range of vaccinations in kidney transplant recipients: Results from a randomized controlled study","volume":"88","author":"Fatly","year":"2024","journal-title":"J Infect"},{"issue":"6","key":"10.1053\/j.ajkd.2025.10.021_bib7","doi-asserted-by":"crossref","first-page":"e480","DOI":"10.1093\/cid\/ciaf107","article-title":"Replacing mycophenolate mofetil by everolimus in kidney transplant recipients to increase vaccine immunogenicity: results of a randomized controlled trial","volume":"81","author":"Messchendorp","year":"2025","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.ajkd.2025.10.021_bib10","first-page":"1","article-title":"St\u00e4ndige impfkommission: empfehlungen der st\u00e4ndigen impfkommission (STIKO) beim Robert Koch-Institut 2025","volume":"4","year":"2025","journal-title":"Epid Bull"},{"issue":"9","key":"10.1053\/j.ajkd.2025.10.021_bib11","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.2215\/CJN.02160311","article-title":"Efficacy of influenza A H1N1\/2009 vaccine in hemodialysis and kidney transplant patients","volume":"6","author":"Crespo","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"38","key":"10.1053\/j.ajkd.2025.10.021_bib12","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1016\/j.vaccine.2013.06.076","article-title":"Serial influenza-vaccination reveals impaired maintenance of specific T-cell memory in patients with end-stage renal failure","volume":"31","author":"Sester","year":"2013","journal-title":"Vaccine"},{"issue":"3","key":"10.1053\/j.ajkd.2025.10.021_bib13","article-title":"Effectiveness of influenza vaccination in patients with end-stage renal disease receiving hemodialysis: a population-based study","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"key":"10.1053\/j.ajkd.2025.10.021_bib14","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s12916-014-0244-9","article-title":"Influenza vaccination in patients with end-stage renal disease: systematic review and assessment of quality of evidence related to vaccine efficacy, effectiveness, and safety","volume":"12","author":"Remschmidt","year":"2014","journal-title":"BMC Med"},{"issue":"18","key":"10.1053\/j.ajkd.2025.10.021_bib15","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1161\/CIRCULATIONAHA.121.057042","article-title":"Influenza vaccination after myocardial infarction: a randomized, double-blind, placebo-controlled, multicenter trial","volume":"144","author":"Fr\u00f6bert","year":"2021","journal-title":"Circulation"},{"issue":"2","key":"10.1053\/j.ajkd.2025.10.021_bib16","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1046\/j.1523-1755.2003.00787.x","article-title":"Influenza vaccine delivery and effectiveness in end-stage renal disease","volume":"63","author":"Gilbertson","year":"2003","journal-title":"Kidney Int"},{"issue":"11","key":"10.1053\/j.ajkd.2025.10.021_bib17","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1093\/cid\/cix1081","article-title":"A systematic review of safety and immunogenicity of influenza vaccination strategies in solid organ transplant recipients","volume":"66","author":"Chong","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1053\/j.ajkd.2025.10.021_bib18","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/cid\/ciw855","article-title":"Two doses of inactivated influenza vaccine improve immune response in solid organ transplant recipients: results of TRANSGRIPE 1-2, a randomized controlled clinical trial","volume":"64","author":"Cordero","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1053\/j.ajkd.2025.10.021_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2015.07.014","article-title":"Influenza vaccination during the first 6 months after solid organ transplantation is efficacious and safe","volume":"21","author":"P\u00e9rez-Romero","year":"2015","journal-title":"Clin Microbiol Infect"},{"issue":"23","key":"10.1053\/j.ajkd.2025.10.021_bib20","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1056\/NEJMoa2509834","article-title":"High-dose influenza vaccine to reduce hospitalizations","volume":"393","author":"Pardo-Seco","year":"2025","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1053\/j.ajkd.2025.10.021_bib21","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1056\/NEJMoa2509907","article-title":"High-dose influenza vaccine effectiveness against hospitalization in older adults","volume":"393","author":"Johansen","year":"2025","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1053\/j.ajkd.2025.10.021_bib22","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.2215\/CJN.03390318","article-title":"High-dose seasonal influenza vaccine in patients undergoing dialysis","volume":"13","author":"Miskulin","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"33","key":"10.1053\/j.ajkd.2025.10.021_bib23","doi-asserted-by":"crossref","first-page":"5178","DOI":"10.1016\/j.vaccine.2020.06.020","article-title":"Comparative safety of high-dose versus standard-dose influenza vaccination in patients with end-stage renal disease","volume":"38","author":"Layton","year":"2020","journal-title":"Vaccine"},{"issue":"4","key":"10.1053\/j.ajkd.2025.10.021_bib24","doi-asserted-by":"crossref","first-page":"e609","DOI":"10.1093\/infdis\/jiaf376","article-title":"Pneumococcal serotype distribution and coverage of existing and pipeline pneumococcal vaccines","volume":"232","author":"King","year":"2025","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1053\/j.ajkd.2025.10.021_bib25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1684\/ecn.2009.0153","article-title":"Antibody response to pneumococcal capsular polysaccharide vaccination in patients with chronic kidney disease","volume":"20","author":"Mahmoodi","year":"2009","journal-title":"Eur Cytokine Netw"},{"issue":"11","key":"10.1053\/j.ajkd.2025.10.021_bib26","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1128\/CVI.00153-16","article-title":"Immunogenicity of 13-valent conjugate pneumococcal vaccine in patients 50 years and older with end-stage renal disease and on dialysis","volume":"23","author":"Mitra","year":"2016","journal-title":"Clin Vaccine Immunol"},{"issue":"4","key":"10.1053\/j.ajkd.2025.10.021_bib27","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13343","article-title":"A randomized, controlled trial comparing the immunogenecity and safety of a 23-valent pneumococcal polysaccharide vaccination to a repeated dose 13-valent pneumococcal conjugate vaccination in kidney transplant recipients","volume":"22","author":"Eriksson","year":"2020","journal-title":"Transpl Infect Dis"},{"issue":"28","key":"10.1053\/j.ajkd.2025.10.021_bib28","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1016\/j.vaccine.2022.05.040","article-title":"Immunogenicity and safety of double dosage of pneumococcal vaccines in adult kidney transplant recipients and waiting list patients: a non-blinded, randomized clinical trial","volume":"40","author":"Larsen","year":"2022","journal-title":"Vaccine"},{"issue":"24","key":"10.1053\/j.ajkd.2025.10.021_bib29","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1016\/j.vaccine.2023.05.003","article-title":"Pneumococcal vaccination coverage at the initiation of chronic dialysis, and its association with mortality during the first year","volume":"41","author":"Pierre","year":"2023","journal-title":"Vaccine"},{"issue":"6","key":"10.1053\/j.ajkd.2025.10.021_bib30","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1053\/j.ajkd.2012.04.018","article-title":"Mortality of dialysis patients according to influenza and pneumococcal vaccination status","volume":"60","author":"Bond","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1053\/j.ajkd.2025.10.021_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046133","article-title":"Randomized, single blind, controlled trial to evaluate the prime-boost strategy for pneumococcal vaccination in renal transplant recipients","volume":"7","author":"Tobudic","year":"2012","journal-title":"PLoS One"},{"issue":"16","key":"10.1053\/j.ajkd.2025.10.021_bib32","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJMoa2213836","article-title":"Efficacy and safety of a bivalent RSV prefusion F vaccine in older adults","volume":"388","author":"Walsh","year":"2023","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1053\/j.ajkd.2025.10.021_bib33","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMoa2209604","article-title":"Respiratory syncytial virus prefusion F protein vaccine in older adults","volume":"388","author":"Papi","year":"2023","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1053\/j.ajkd.2025.10.021_bib34","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMoa2307079","article-title":"Efficacy and safety of an mRNA-based RSV preF vaccine in older adults","volume":"389","author":"Wilson","year":"2023","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1053\/j.ajkd.2025.10.021_bib35","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMoa2509810","article-title":"RSV prefusion F vaccine for prevention of hospitalization in older adults","volume":"394","author":"Lassen","year":"2025","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1053\/j.ajkd.2025.10.021_bib36","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1001\/jama.2025.15405","article-title":"Bivalent RSV prefusion F protein-based vaccine for preventing cardiovascular hospitalizations in older adults: a prespecified analysis of the DAN-RSV Trial","volume":"334","author":"Lassen","year":"2025","journal-title":"JAMA"},{"key":"10.1053\/j.ajkd.2025.10.021_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2023.105399","article-title":"Focusing on severe infections with the respiratory syncytial virus (RSV) in adults: risk factors, symptomatology and clinical course compared to influenza A\/B and the original SARS-CoV-2 strain","volume":"161","author":"Ambrosch","year":"2023","journal-title":"J Clin Virol"},{"issue":"3","key":"10.1053\/j.ajkd.2025.10.021_bib38","article-title":"Immunogenicity and safety of the bivalent respiratory syncytial virus prefusion F subunit vaccine in immunocompromised or renally impaired adults","volume":"13","author":"Almeida","year":"2025","journal-title":"Vaccines (Basel)"},{"issue":"10","key":"10.1053\/j.ajkd.2025.10.021_bib39","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.31749","article-title":"Immunogenicity rates after SARS-CoV-2 vaccination in people with end-stage kidney disease: a systematic review and meta-analysis","volume":"4","author":"Chen","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1053\/j.ajkd.2025.10.021_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.888385","article-title":"Risk factors for weak antibody response of SARS-CoV-2 vaccine in adult solid organ transplant recipients: a systemic review and meta-analysis","volume":"13","author":"Zong","year":"2022","journal-title":"Front Immunol"},{"key":"10.1053\/j.ajkd.2025.10.021_bib41","series-title":"Global Hepatitis Report 2024: Action for Access in Low- and Middle-Income Countries","year":"2024"},{"issue":"46","key":"10.1053\/j.ajkd.2025.10.021_bib42","doi-asserted-by":"crossref","first-page":"5306","DOI":"10.1016\/j.vaccine.2013.05.067","article-title":"Immunogenicity and safety of an investigational hepatitis B vaccine with a toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in patients with chronic kidney disease","volume":"31","author":"Janssen","year":"2013","journal-title":"Vaccine"},{"issue":"2","key":"10.1053\/j.ajkd.2025.10.021_bib43","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/ndt\/gfac039","article-title":"A real world comparison of HepB (Engerix-B\u00ae) and HepB-CpG (Heplisav-B\u00ae) vaccine seroprotection in patients receiving maintenance dialysis","volume":"38","author":"Manley","year":"2022","journal-title":"Nephrol Dial Transplant"},{"issue":"18","key":"10.1053\/j.ajkd.2025.10.021_bib44","author":"Girndt","year":"2022","journal-title":"Hum Vaccin Immunother"},{"issue":"5","key":"10.1053\/j.ajkd.2025.10.021_bib45","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1111\/j.1523-1755.2005.00689.x","article-title":"Immunogenicity and safety of an adjuvanted hepatitis B vaccine in pre-hemodialysis and hemodialysis patients","volume":"68","author":"Tong","year":"2005","journal-title":"Kidney Int"},{"issue":"8","key":"10.1053\/j.ajkd.2025.10.021_bib46","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/j.1525-1497.2005.0150.x","article-title":"The incidence of herpes zoster in a United States administrative database","volume":"20","author":"Insinga","year":"2005","journal-title":"J Gen Intern Med"},{"issue":"11","key":"10.1053\/j.ajkd.2025.10.021_bib47","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","article-title":"Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older","volume":"375","author":"Cunningham","year":"2016","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1053\/j.ajkd.2025.10.021_bib48","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1093\/infdis\/jiy095","article-title":"Immune responses to a recombinant glycoprotein E herpes zoster vaccine in adults aged 50 years or older","volume":"217","author":"Cunningham","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1053\/j.ajkd.2025.10.021_bib49","article-title":"Herpes zoster risk in immunocompromised adults in the United States: a systematic review","author":"McKay","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1053\/j.ajkd.2025.10.021_bib50","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1053\/j.ajkd.2011.10.049","article-title":"Risk of herpes zoster in patients treated with long-term hemodialysis: a matched cohort study","volume":"59","author":"Kuo","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"10.1053\/j.ajkd.2025.10.021_bib51","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1080\/21645515.2019.1627818","article-title":"Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trials","volume":"15","author":"Oostvogels","year":"2019","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"10.1053\/j.ajkd.2025.10.021_bib52","doi-asserted-by":"crossref","DOI":"10.1111\/tid.12874","article-title":"A randomized, placebo-controlled phase I trial of live, attenuated herpes zoster vaccine in subjects with end-stage renal disease immunized prior to renal transplantation","volume":"20","author":"Miller","year":"2018","journal-title":"Transpl Infect Dis"},{"key":"10.1053\/j.ajkd.2025.10.021_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105335","article-title":"The inactivated herpes zoster vaccine HZ\/su induces a varicella zoster virus specific cellular and humoral immune response in patients on dialysis","volume":"108","author":"Hielscher","year":"2024","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1053\/j.ajkd.2025.10.021_bib54","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/cid\/civ930","article-title":"Effectiveness of herpes zoster vaccine in patients 60 years and older with end-stage renal disease","volume":"62","author":"Tseng","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1053\/j.ajkd.2025.10.021_bib55","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/cid\/ciz177","article-title":"Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in chronically immunosuppressed adults following renal transplant: a phase 3, randomized clinical trial","volume":"70","author":"Vink","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1053\/j.ajkd.2025.10.021_bib56","doi-asserted-by":"crossref","first-page":"80","DOI":"10.15585\/mmwr.mm7103a2","article-title":"Use of recombinant zoster vaccine in immunocompromised adults aged \u226519 years: recommendations of the Advisory Committee on Immunization Practices - United States, 2022","volume":"71","author":"Anderson","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1053\/j.ajkd.2025.10.021_bib57","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/ndt\/gfy225","article-title":"Failure of first meningococcal vaccination in patients with atypical haemolytic uraemic syndrome treated with eculizumab","volume":"35","author":"G\u00e4ckler","year":"2020","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1053\/j.ajkd.2025.10.021_bib58","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/tid.12359","article-title":"Low immunogenicity of quadrivalent meningococcal vaccines in solid organ transplant recipients","volume":"17","author":"Wyplosz","year":"2015","journal-title":"Transpl Infect Dis"},{"issue":"1","key":"10.1053\/j.ajkd.2025.10.021_bib59","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/ndt\/gfv444","article-title":"Immunogenicity and safety of quadrivalent human papillomavirus types 6\/11\/16\/18 recombinant vaccine in chronic kidney disease stage IV, V and VD","volume":"32","author":"Praditpornsilpa","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2025.10.021_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.1057454","article-title":"Human papillomavirus infection-related cancer risk for kidney transplant recipients during adult life can be reduced by vaccination during childhood and adolescence","volume":"10","author":"Nailescu","year":"2022","journal-title":"Front Pediatr"},{"issue":"7","key":"10.1053\/j.ajkd.2025.10.021_bib61","doi-asserted-by":"crossref","DOI":"10.1111\/petr.14341","article-title":"Human papillomavirus-related cancer risk for solid organ transplant recipients during adult life and early prevention strategies during childhood and adolescence","volume":"26","author":"Nailescu","year":"2022","journal-title":"Pediatr Transplant"},{"key":"10.1053\/j.ajkd.2025.10.021_bib62","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/0272-6386(95)90491-3","article-title":"Tetanus immunization and its association to hepatitis B vaccination in patients with chronic renal failure","volume":"26","author":"Girndt","year":"1995","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1053\/j.ajkd.2025.10.021_bib63","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/ajkd.2001.29223","article-title":"A 5-year follow-up on antibody response after diphtheria and tetanus vaccination in hemodialysis patients","volume":"38","author":"Kr\u00fcger","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2025.10.021_bib64","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1093\/ndt\/17.10.1825","article-title":"Active immunization against hepatitis A in dialysis patients","volume":"17","author":"Fleischmann","year":"2002","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1053\/j.ajkd.2025.10.021_bib65","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/tid.12217","article-title":"Efficacy and safety of hepatitis A vaccination in kidney transplant recipients","volume":"16","author":"Jeon","year":"2014","journal-title":"Transpl Infect Dis"},{"issue":"3","key":"10.1053\/j.ajkd.2025.10.021_bib66","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfaf048","article-title":"Monkeypox infection in kidney transplant recipients","volume":"18","author":"Suliman","year":"2025","journal-title":"Clin. Kidney J"},{"issue":"23","key":"10.1053\/j.ajkd.2025.10.021_bib67","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1016\/j.vaccine.2019.04.010","article-title":"Comparison of the immunogenicity of Dukoral oral cholera vaccine between renal transplant recipients on either a calcineurin inhibitor or mycophenolate - a controlled trial","volume":"37","author":"Jonker","year":"2019","journal-title":"Vaccine"},{"issue":"4","key":"10.1053\/j.ajkd.2025.10.021_bib68","doi-asserted-by":"crossref","DOI":"10.1590\/2175-8239-jbn-2023-0202en","article-title":"Safety and immunogenicity of the yellow fever vaccine for patients with end-stage renal disease","volume":"46","author":"Distenhreft","year":"2024","journal-title":"J Bras Nefrol"},{"issue":"3","key":"10.1053\/j.ajkd.2025.10.021_bib69","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1399-3062.2011.00686.x","article-title":"Yellow fever vaccination in organ transplanted patients: is it safe? A multicenter study","volume":"14","author":"Azevedo","year":"2012","journal-title":"Transpl Infect Dis"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638626007092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638626007092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T23:24:45Z","timestamp":1781825085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638626007092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":67,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0272638626007092"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2025.10.021","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccinations to Prevent Infections in Adult Individuals With CKD and After Kidney Transplantation: A Review","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2025.10.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}